Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Miromatrix Medical Inc (NQ: MIRO )

1.150 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.150
Bid (Size) 0.3368 (8)
Ask (Size) 1.150 (1)
Prev. Close 1.150
Today's Range 1.150 - 1.150
52wk Range 0.9065 - 4.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Presenting at the 2023 American Transplant Congress
From Miromatrix Medical Inc.
Via GlobeNewswire

Performance

YTD
-61.67%
-61.67%
1 Month
+0.88%
+0.88%
3 Month
-28.13%
-28.13%
6 Month
-71.67%
-71.67%
1 Year
-70.36%
-70.36%

More News

Read More
Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Medical: Q1 Earnings Insights
Via Benzinga
Earnings Preview For Miromatrix Medical
Via Benzinga
Why Miromatrix Medical Shares Are Falling 40%
Via Benzinga
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix to Report First Quarter 2023 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med
From Miromatrix Medical Inc.
Via GlobeNewswire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From CareDx, Inc.
Via Business Wire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
Crude Oil Down 1.5%; Campbell Soup Posts Upbeat Earnings
Via Benzinga
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Drops Over 100 Points; Kimball International Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
TSLA Stock: Why This Analyst Just Downgraded Tesla Shares
Via InvestorPlace
Why Is Occidental Petroleum (OXY) Stock Up Today?
Via InvestorPlace
Stocks Edge Higher; US Trade Deficit Widens In January
Via Benzinga
Why Is Miromatrix Medical (MIRO) Stock Down 41% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
From Miromatrix Medical Inc.
Via GlobeNewswire
Why Miromatrix Medical Shares Are Getting Obliterated After Hours
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.